Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Journal of Clinical Pathology
|
February 5, 2002
How should the chest wall be opened at necropsy?
J E C Walker, G N Rutty, B Rodgers, et al.
Biomedical Instrumentation & Technology
|
September 1, 1991
Application of piezo film technology for the quantitative assessment of pruritus
T L Talbot, J M Schmitt, N V Bergasa, et al.
Annals of Internal Medicine
|
August 1, 1995
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial
N V Bergasa, D W Alling, T L Talbot, et al.
Gastroenterology
|
February 1, 1992
A controlled trial of naloxone infusions for the pruritus of chronic cholestasis
N V Bergasa, T L Talbot, D W Alling, et al.
The Journal of Clinical Investigation
|
July 1, 1991
Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis
H R Alexander, B C Sheppard, J C Jensen, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Journal of Clinical Pathology
|
February 5, 2002
How should the chest wall be opened at necropsy?
J E C Walker, G N Rutty, B Rodgers, et al.
Biomedical Instrumentation & Technology
|
September 1, 1991
Application of piezo film technology for the quantitative assessment of pruritus
T L Talbot, J M Schmitt, N V Bergasa, et al.
Annals of Internal Medicine
|
August 1, 1995
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial
N V Bergasa, D W Alling, T L Talbot, et al.
Gastroenterology
|
February 1, 1992
A controlled trial of naloxone infusions for the pruritus of chronic cholestasis
N V Bergasa, T L Talbot, D W Alling, et al.
The Journal of Clinical Investigation
|
July 1, 1991
Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis
H R Alexander, B C Sheppard, J C Jensen, et al.
Page
of 2